Abstract
A 53-year-old man complained of weight loss, night sweats, and splenomegaly. The patient was diagnosed with stage IV hepatosplenic γδ T-cell non-Hodgkin's lymphoma, a highly aggressive and rare form of peripheral T-cell lymphoma. After completing CHOP chemotherapy, the patient relapsed. He did not respond to subsequent alemtuzumab therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 241-243 |
| Number of pages | 3 |
| Journal | European journal of internal medicine |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 May 2007 |
Keywords
- Alemtuzumab
- Chemotherapy
- Hepatosplenic γδ T-cell lymphoma